Aktsiaselts Mammograaf

Active Registry code 10233840 AS Tallinn Registered 4 Aug 1997

Aktsiaselts Mammograaf is a AS based in Tallinn, registry code 10233840, status: active. Main activity: Medical specialists activities. Its annual report for 2025 shows revenue of €4 924 682 and 33 employees.

Turnover

—

State taxes

186 265 €

↑ 0.2% vs Q2 2026

Labour taxes

193 346 €

↓ 1.5% vs Q2 2026

Employees

±0 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Human health activities · EMTAK 86

Labour taxes per employee 5 226 €

above 90% of companies

industry median 2 177 € · companies in the industry: 1 696
Revenue · 2025 4.9 mn €

above 98% of companies

industry median 20 811 € · companies in the industry: 3 373
Net profit margin · 2025 9.0 %

above 52% of companies

industry median 8.3 % · companies in the industry: 2 759

Taxes and turnover

Q4 2023 – Q3 2026

Labour taxes per employee, € Q3 2026: 5 226 € · −1.5% vs Q2 2026 · industry median 2 177 € · above 90% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 37 · +0.0% vs Q2 2026

State taxes, € thousand Q3 2026: 186 265 € · +0.2% vs Q2 2026

Figures by quarter
Quarter	Turnover, €	State taxes, €	Labour taxes, €	Employees
Q3 2026	—	186 265	193 346	37
Q2 2026	—	185 939	196 246	37
Q1 2026	—	176 957	187 534	36
Q4 2025	—	188 503	190 180	34
Q3 2025	—	177 447	179 024	33
Q2 2025	—	174 502	173 347	34
Q1 2025	—	168 636	169 036	32
Q4 2024	—	159 723	160 212	31
Q3 2024	—	162 134	163 260	31
Q2 2024	—	161 674	158 028	31
Q1 2024	—	155 248	153 376	31
Q4 2023	—	143 033	142 958	32
Q3 2023	—	143 314	143 971	29
Q2 2023	—	135 350	134 962	31
Q1 2023	—	131 385	133 497	36
Q4 2022	—	121 634	113 605	34
Q3 2022	—	121 122	117 433	32
Q2 2022	—	102 403	100 051	29
Q1 2022	—	102 858	98 949	29

Labour taxes per employee per month

1 742 €

Q3 2026 · calculated from EMTA data

Financials by year

2016 – 2025

Revenue, € thousand 2025: 4 924 682 € · +4.6% vs 2024 · industry median 20 811 € · above 98% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € thousand 2025: 443 378 € · +153.8% vs 2024 · industry median 1 071 € · above 98% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 9.0 % · +5.3 pp vs the year before · industry median 8.3 % · above 52% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 2 142 004 € · +50.6% vs 2024

Equity, € thousand 2025: 1 427 213 € · +17.4% vs 2024

Employees 2025: 33 · +3.1% vs 2024 · industry median 2 · above 98% of the industry

Company
Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year	Revenue, €	Net profit, €	Labour costs, €	Assets, €	Equity, €	Employees
2025	4 924 682	443 378	1 675 185	2 142 004	1 427 213	33
2024	4 709 173	174 698	1 493 361	1 422 628	1 215 834	32
2023	4 346 779	305 556	1 326 266	1 568 233	1 374 054	32
2022	3 666 993	310 163	1 051 570	1 487 546	1 335 101	30
2021	3 178 466	230 897	873 210	1 416 290	1 291 691	24
2020	2 958 622	358 415	811 853	1 492 467	1 348 293	24
2019	2 596 691	329 092	677 821	1 262 121	1 162 366	23
2018	—	—	—	—	—	22
2017	—	—	—	—	—	20
2016	—	—	—	—	—	21
2015	—	—	—	—	—	14
2014	—	—	—	—	—	16
2013	—	—	—	—	—	15
2012	—	—	—	—	—	0
2011	—	—	—	—	—	16
2007	—	—	—	—	—	14
2006	—	—	—	—	—	9
2005	—	—	—	—	—	9
2004	—	—	—	—	—	9
2003	—	—	—	—	—	12
2002	—	—	—	—	—	10
2001	—	—	—	—	—	8
2000	—	—	—	—	—	7
1999	—	—	—	—	—	7
1998	—	—	—	—	—	4
1997	—	—	—	—	—	6

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin

9.0 %

Net profit / revenue

Return on equity (ROE)

31.1 %

Net profit / equity

Return on assets (ROA)

20.7 %

Net profit / assets

Equity ratio

66.6 %

Equity / assets

Debt ratio

33.4 %

Liabilities / assets

Current ratio

2.37

Current assets / current liabilities

Revenue per employee

149 233 €

Revenue / average full-time employees

Labour cost per employee per month

4 230 €

Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister

Annual reports
Year	Period	Filed	Report	Documents
2025	1 Jan 2025 – 31 Dec 2025	30 Jun 2026	Company’s own · audited	e-Äriregister
2024	1 Jan 2024 – 31 Dec 2024	30 Jun 2025	Company’s own · audited	e-Äriregister
2023	1 Jan 2023 – 31 Dec 2023	1 Jul 2024	Company’s own · audited	e-Äriregister
2022	1 Jan 2022 – 31 Dec 2022	30 Jun 2023	Company’s own · audited	e-Äriregister
2021	1 Jan 2021 – 31 Dec 2021	30 Jun 2022	Company’s own · audited	e-Äriregister
2020	1 Jan 2020 – 31 Dec 2020	30 Jun 2021	Company’s own · audited	e-Äriregister
2019	1 Jan 2019 – 31 Dec 2019	31 Oct 2020	Company’s own · audited	e-Äriregister

Board

Nasdaq CSD SE
Keeper of the share ledger · since 28 Sep 2017
Silver Raudsepp
Board member · since 14 Dec 2009
Anne Pardla
Board member · since 19 Aug 2016

Right of representation

Any member of the management board may represent the public limited company in all transactions.

Owners

No owner information.

Owner in

Beneficial owners

Silver Raudsepp
Direct ownership · since 3 Sep 2018
ÜLLE RAUDSEPP
Direct ownership · since 3 Sep 2018

Founders and other persons

Alar Heinaste
Audit firm · 16 Apr 2008
Gabler Audit OÜ
Audit firm · 12 May 2023
Ülle Raudsepp
Chairman of the supervisory board · 27 May 2026
Peeter Raudvere
Supervisory board member · 27 May 2026
Theo Raudsepp
Supervisory board member · 27 May 2026
Omanikukonto: PEETER RAUDVERE
Shareholder · 11 725 € · 16 Aug 2023
Omanikukonto: Silver Raudsepp
Shareholder · 31 080 € · 16 Aug 2023
Omanikukonto: ÜLLE RAUDSEPP
Shareholder · 21 000 € · 16 Aug 2023

shared board members, owners or beneficial owners

Activities (EMTAK)

86221Medical specialists activities Main

Rulings 33

All rulings (PDF)

Rulings
Number, date	Title	Deadline	State	Document
Ä 10015303 / 22 5 Jun 2026	Amendment entry		In force 5 Jun 2026	PDF
Ä 10015303 / M12 21 Jun 2019	Ruling to correct data outside an entry	1 Jul 2019	In force 21 Jun 2019	PDF
K 10015303 / 21 27 Dec 2018	Commercial pledge deleted		In force 27 Dec 2018	PDF
Ä 10015303 / 20 29 Jun 2018	Amendment entry		In force 29 Jun 2018	PDF
Ä 10015303 / 19 16 Jan 2018	Amendment entry		In force 16 Jan 2018	PDF
Ä 10015303 / 18 7 Nov 2017	Amendment entry		In force 7 Nov 2017	PDF
Ä 10015303 / 17 28 Sep 2017	Amendment entry		In force 28 Sep 2017	PDF
Ä 10015303 / 16 11 Aug 2017	Amendment entry		In force 11 Aug 2017	PDF
Ä 10015303 / M11 7 Aug 2017	Ruling to eliminate deficiencies	22 Aug 2017	Deficiencies eliminated 11 Aug 2017	PDF
Ä 10015303 / 15 17 Jan 2017	Amendment under Commercial Code § 525 (2)		In force 17 Jan 2017	PDF
Ä 10015303 / 14 19 Aug 2016	Amendment entry		In force 19 Aug 2016	PDF
Ä 10015303 / M10 16 Aug 2016	Ruling to eliminate deficiencies	5 Sep 2016	Deficiencies eliminated 19 Aug 2016	PDF
Ä 10015303 / 13 29 Jan 2016	Amendment entry		In force 29 Jan 2016	PDF
Ä 10015303 / M9 28 Jan 2016	Ruling to eliminate deficiencies	17 Feb 2016	Deficiencies eliminated 29 Jan 2016	PDF
Ä 10015303 / 12 14 Jan 2016	Amendment entry		In force 14 Jan 2016	PDF
K 10015303 / 11 30 Oct 2015	Commercial pledge entered		In force 30 Oct 2015	PDF
Ä 10015303 / M8 5 Jan 2015	Ruling to correct data outside an entry	4 Feb 2015	Deficiencies eliminated 16 Jan 2015	PDF
Ä 10015303 / 10 16 Nov 2011	Amendment entry		In force 16 Nov 2011	PDF
Ä 10015303 / M7 10 Oct 2011	Ruling to eliminate deficiencies	10 Nov 2011	In force 10 Oct 2011	PDF
Ä 15303 / 9 14 Dec 2009	Amendment entry		In force 14 Dec 2009	PDF
Ä 15303 / M6 8 Dec 2009	Ruling to eliminate deficiencies		In force 8 Dec 2009	PDF
Ä 15303 / 8 3 Dec 2008	Deletion of activities from the registry card		In force 12 Dec 2008	PDF
Ä 15303 / 7 4 Jun 2008	Transformation entry without a new registry card		In force 4 Jun 2008	PDF
K 118392 / 2 4 Jun 2008	Compliance with Commercial Code § 33 (7.1)		In force 4 Jun 2008	PDF
Ä 15303 / M5 29 May 2008	Ruling to eliminate deficiencies (to be served)		Deficiencies eliminated 4 Jun 2008	PDF
K 118392 14 May 2008	Commercial pledge entered		In force 14 May 2008	PDF
Ä 15303 / 6 13 Mar 2008	Note on registration of shares in the Estonian central register of securities		In force 13 Mar 2008	PDF
Ä 15303 / 5 15 May 2007	Amendment entry		In force 15 May 2007	PDF
Ä 15303 / M4 22 Sep 2006	Fine for not filing the report	9 Nov 2006	In force 7 Oct 2006	PDF
Ä 15303 / M3 22 Sep 2006	Fine for not filing the report	18 Nov 2006	In force 18 Oct 2006	PDF
Ä 15303 / M2 21 Sep 2006	Fine for not filing the report	2 Dec 2006	In force 20 Oct 2006	PDF
Ä 15303 / 4 20 Dec 2005	Amendment entry		In force	PDF
Ä 15303 / M1 25 Oct 2005	Ruling to eliminate deficiencies (to be served)	12 Dec 2005	In force	PDF

Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data

Aktsiaselts Mammograaf

Position in the industry Human health activities · EMTAK 86

Taxes and turnover

Financials by year

Financial ratios for 2025

Annual reports

Board

Right of representation

Owners

Owner in

Beneficial owners

Founders and other persons

Related companies

Activities (EMTAK)

Rulings 33